Compare $ALZN vs $IMNN | Chartloom

Compare

$ALZN vs $IMNN

Alzamend Neuro Inc · Imunon Inc

ALZN

Alzamend Neuro Inc

IMNN

Imunon Inc

Compare $ALZN vs $IMNN

Comparing Alzamend Neuro Inc and Imunon Inc

ALZNAlzamend Neuro Inc

IMNNImunon Inc

ALZNAlzamend Neuro Inc

Market cap

$6M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-29.5%

52W performance

-47.0%

FCF yield

-106.6%

IMNNImunon Inc

Market cap

$5M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-72.7%

52W performance

-79.7%

FCF yield

-334.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALZN

IMNN

Detailed metrics comparison

ALZN

Alzamend Neuro Inc

IMNN

Imunon Inc

Market Cap

ALZN$6M

IMNN$5M

Enterprise Value

ALZN$-1M

IMNN$5M

Price

ALZN$1.34

IMNN$1.08

P/E Ratio

ALZNN/A

IMNNN/A

P/S Ratio

ALZN0.00x

IMNN13.81x

EV/Sales

ALZN0.00x

IMNN14.14x

EV/EBITDA

ALZN0.00x

IMNN0.00x

P/B Ratio

ALZN1.14x

IMNN1.71x

P/FCF Ratio

ALZNN/A

IMNNN/A

EV/FCF

ALZN0.17x

IMNN-0.31x

PEG Ratio

ALZNN/A

IMNNN/A

Forward P/E (NTM)

ALZNN/A

IMNNN/A

Forward P/S (NTM)

ALZNN/A

IMNNN/A

Revenue (TTM)

ALZN$0

IMNN$0

Revenue Growth (YoY)

ALZNN/A

IMNNN/A

Forward Rev Growth

ALZN0.0%

IMNN205.5%

Gross Margin (TTM)

ALZN0.0%

IMNN34.1%

Operating Margin (TTM)

ALZN0.0%

IMNN0.0%

EBITDA Margin (TTM)

ALZN0.0%

IMNN0.0%

Net Margin (TTM)

ALZN0.0%

IMNN0.0%

FCF Margin (TTM)

ALZNN/A

IMNNN/A

Net Income (TTM)

ALZN$-9M

IMNN$-15M

FCF (TTM)

ALZN$-7M

IMNN$-15M

EPS (TTM)

ALZN-$2.03

IMNN-$2.82

ROE (TTM)

ALZN-27788.0%

IMNN-31490.0%

ROA (TTM)

ALZN-18419.0%

IMNN-13292.0%

ROIC (TTM)

ALZN-27788.0%

IMNN-22880.0%

Cash

ALZN$8M

IMNN$7M

Debt

ALZN$0

IMNN$7M

Net Cash/Debt

ALZN$8M

IMNN$-170K

Current Ratio (TTM)

ALZN3.01x

IMNN1.82x

Quick Ratio (TTM)

ALZN2.77x

IMNN1.44x

Debt/Equity (TTM)

ALZN0.00x

IMNN1.68x

Debt/Assets (TTM)

ALZN0.0%

IMNN0.0%

Interest Coverage (TTM)

ALZNN/A

IMNNN/A

Net Debt/EBITDA (TTM)

ALZN0.00x

IMNN0.00x

Beta

ALZN0.43

IMNN2.08

52W Performance

ALZN-47.0%

IMNN-79.7%

YTD Performance

ALZN-29.5%

IMNN-72.7%

% from 52W High

ALZN-50.0%

IMNN-80.0%

% from 52W Low

ALZN59.5%

IMNN12.5%

Asset Turnover (TTM)

ALZN0.00x

IMNN0.01x

FCF Yield (TTM)

ALZN-106.6%

IMNN-334.7%

Earnings Yield (TTM)

ALZN-141.7%

IMNN-324.8%

Dividend Yield (TTM)

ALZNN/A

IMNNN/A

Rule of 40

ALZN0.0

IMNN0.0

EV/GP/RG

ALZNN/A

IMNNN/A

Ticker research

View ALZN research View IMNN research

Metric	ALZN Alzamend Neuro Inc	IMNN Imunon Inc
Market & Valuation
Market Cap	$6M	$5M
Enterprise Value	$-1M	$5M
Price	$1.34	$1.08
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	13.81x
EV/Sales	0.00x	14.14x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.14x	1.71x
P/FCF Ratio	N/A	N/A
EV/FCF	0.17x	-0.31x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	205.5%
Profitability
Gross Margin (TTM)	0.0%	34.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-9M	$-15M
FCF (TTM)	$-7M	$-15M
EPS (TTM)	-$2.03	-$2.82
ROE (TTM)	-27788.0%	-31490.0%
ROA (TTM)	-18419.0%	-13292.0%
ROIC (TTM)	-27788.0%	-22880.0%
Financial Health
Cash	$8M	$7M
Debt	$0	$7M
Net Cash/Debt	$8M	$-170K
Current Ratio (TTM)	3.01x	1.82x
Quick Ratio (TTM)	2.77x	1.44x
Debt/Equity (TTM)	0.00x	1.68x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.43	2.08
52W Performance	-47.0%	-79.7%
YTD Performance	-29.5%	-72.7%
% from 52W High	-50.0%	-80.0%
% from 52W Low	59.5%	12.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-106.6%	-334.7%
Earnings Yield (TTM)	-141.7%	-324.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ALZN research	View IMNN research

Valuation

P/S Ratio

ALZN

0.00x

IMNN

13.81x

EV/FCF

IMNN

-0.31x

ALZN

0.17x

Growth & revenue

Forward Revenue Growth

IMNN

205.5%

ALZN

0.0%

Profitability & performance

Gross Margin

IMNN

34.1%

ALZN

0.0%

ROE

ALZN

-27788.0%

IMNN

-31490.0%

FCF Yield %

ALZN

-106.6%

IMNN

-334.7%

52-Week Performance

ALZN

-47.0%

IMNN

-79.7%

Detailed metrics comparison

ALZN

Alzamend Neuro Inc

IMNN

Imunon Inc

Market Cap

ALZN$6M

IMNN$5M

Enterprise Value

ALZN$-1M

IMNN$5M

Price

ALZN$1.34

IMNN$1.08

P/E Ratio

ALZNN/A

IMNNN/A

P/S Ratio

ALZN0.00x

IMNN13.81x

EV/Sales

ALZN0.00x

IMNN14.14x

EV/EBITDA

ALZN0.00x

IMNN0.00x

P/B Ratio

ALZN1.14x

IMNN1.71x

P/FCF Ratio

ALZNN/A

IMNNN/A

EV/FCF

ALZN0.17x

IMNN-0.31x

PEG Ratio

ALZNN/A

IMNNN/A

Forward P/E (NTM)

ALZNN/A

IMNNN/A

Forward P/S (NTM)

ALZNN/A

IMNNN/A

Revenue (TTM)

ALZN$0

IMNN$0

Revenue Growth (YoY)

ALZNN/A

IMNNN/A

Forward Rev Growth

ALZN0.0%

IMNN205.5%

Gross Margin (TTM)

ALZN0.0%

IMNN34.1%

Operating Margin (TTM)

ALZN0.0%

IMNN0.0%

EBITDA Margin (TTM)

ALZN0.0%

IMNN0.0%

Net Margin (TTM)

ALZN0.0%

IMNN0.0%

FCF Margin (TTM)

ALZNN/A

IMNNN/A

Net Income (TTM)

ALZN$-9M

IMNN$-15M

FCF (TTM)

ALZN$-7M

IMNN$-15M

EPS (TTM)

ALZN-$2.03

IMNN-$2.82

ROE (TTM)

ALZN-27788.0%

IMNN-31490.0%

ROA (TTM)

ALZN-18419.0%

IMNN-13292.0%

ROIC (TTM)

ALZN-27788.0%

IMNN-22880.0%

Cash

ALZN$8M

IMNN$7M

Debt

ALZN$0

IMNN$7M

Net Cash/Debt

ALZN$8M

IMNN$-170K

Current Ratio (TTM)

ALZN3.01x

IMNN1.82x

Quick Ratio (TTM)

ALZN2.77x

IMNN1.44x

Debt/Equity (TTM)

ALZN0.00x

IMNN1.68x

Debt/Assets (TTM)

ALZN0.0%

IMNN0.0%

Interest Coverage (TTM)

ALZNN/A

IMNNN/A

Net Debt/EBITDA (TTM)

ALZN0.00x

IMNN0.00x

Beta

ALZN0.43

IMNN2.08

52W Performance

ALZN-47.0%

IMNN-79.7%

YTD Performance

ALZN-29.5%

IMNN-72.7%

% from 52W High

ALZN-50.0%

IMNN-80.0%

% from 52W Low

ALZN59.5%

IMNN12.5%

Asset Turnover (TTM)

ALZN0.00x

IMNN0.01x

FCF Yield (TTM)

ALZN-106.6%

IMNN-334.7%

Earnings Yield (TTM)

ALZN-141.7%

IMNN-324.8%

Dividend Yield (TTM)

ALZNN/A

IMNNN/A

Rule of 40

ALZN0.0

IMNN0.0

EV/GP/RG

ALZNN/A

IMNNN/A

Ticker research

View ALZN research View IMNN research

Metric	ALZN Alzamend Neuro Inc	IMNN Imunon Inc
Market & Valuation
Market Cap	$6M	$5M
Enterprise Value	$-1M	$5M
Price	$1.34	$1.08
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	13.81x
EV/Sales	0.00x	14.14x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.14x	1.71x
P/FCF Ratio	N/A	N/A
EV/FCF	0.17x	-0.31x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	205.5%
Profitability
Gross Margin (TTM)	0.0%	34.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-9M	$-15M
FCF (TTM)	$-7M	$-15M
EPS (TTM)	-$2.03	-$2.82
ROE (TTM)	-27788.0%	-31490.0%
ROA (TTM)	-18419.0%	-13292.0%
ROIC (TTM)	-27788.0%	-22880.0%
Financial Health
Cash	$8M	$7M
Debt	$0	$7M
Net Cash/Debt	$8M	$-170K
Current Ratio (TTM)	3.01x	1.82x
Quick Ratio (TTM)	2.77x	1.44x
Debt/Equity (TTM)	0.00x	1.68x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.43	2.08
52W Performance	-47.0%	-79.7%
YTD Performance	-29.5%	-72.7%
% from 52W High	-50.0%	-80.0%
% from 52W Low	59.5%	12.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-106.6%	-334.7%
Earnings Yield (TTM)	-141.7%	-324.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ALZN research	View IMNN research